Skip to content

Author: API User

Saudi Fund for Development Announces its First Presence in Serbia by Financing 3 Development Projects, Worth $205 Million

By API User

BELGRADE, Serbia–BUSINESS WIRE– The Saudi Fund for Development (SFD) has signed three development loan agreements with the Republic of Serbia worth $205 million to fund key projects supporting the agriculture, education and energy sectors. This partnership, marking SFD’s first presence in Serbia, is aimed at fostering the country’s long-term socioeconomic growth. The agreements were signed … Continued

ABB’s Stuart Thompson Named Future of Field Service 2024 Stand Out 50 Winner

By API User

Under Thompson’s leadership, ABB’s Electrification Service division has significantly expanded through strategic investments and acquisitions of technology-focused businesses, growing by 37% globally since forming Future of Field Service Stand Out 50 Awards recognizes service leaders distinguished by their commitment to service excellence and meaningful impact ZURICH–BUSINESS WIRE– ABB Electrification Service President Stuart Thompson has been … Continued

Everen Specialty Limited Announces Retirement of Jerry Rivers

By API User

HAMILTON, Bermuda–BUSINESS WIRE– Everen Specialty Limited announced today that Jerry Rivers, Senior Vice President, and Chief Operating Officer, will retire on March 31, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241016767824/en/ Jerry Rivers (Photo: Business Wire) John Talarico, Everen Specialty’s Chair, stated, “On behalf of the Board of Directors, the management … Continued

Time to make a noise about workplace hearing damage as 11 per cent of Australians experience it, new Hearing Australia research reveals

By API User

MEDIA RELEASE17 October 2024   Time to make a noise about workplace hearing damage as 11 per cent of Australians experience it, new Hearing Australia research reveals Almost 25 per cent of Australians know someone suffering workplace-related hearing damage but one-in-three give little thought to protecting their own hearing, new research¹ from Hearing Australia shows. … Continued

Bitget Wallet Becomes The Second Most Downloaded App Closing in on Binance

By API User

Bitget Wallet Surpasses 40M users with 100% Growth in 6 Months, Emerging as A Web3 Gateway Over Crypto Exchanges VICTORIA, Seychelles, Oct. 16, 2024 (GLOBE NEWSWIRE) — Bitget Wallet, the leading Web3 non-custodial wallet, has seen nearly 6 million app downloads in September, becoming the second most downloaded crypto app worldwide trailing Binance and surpassing … Continued

NTT DATA, Inc. Announces Stijn Nauwelaerts as Chief People Officer

By API User

Microsoft Corporate VP HR joins NTT DATA, Inc. to help drive the organization’s transformation LONDON–BUSINESS WIRE– NTT DATA, a global digital business and IT services leader, today announced that Stijn Nauwelaerts will join NTT DATA, Inc. as its Chief People Officer on 18November 2024. He will lead all aspects of the people and talent strategy … Continued

Articul8 AI Signs Strategic Collaboration Agreement with AWS to Deliver Generative AI Solutions to Enterprises

By API User

SANTA CLARA, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) — Articul8 AI (Articul8), a Generative Artificial Intelligence (GenAI) enterprise software company, announced today that it has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS), with plans to help customers accelerate the development and deployment of GenAI applications in production on AWS. While there has been strong overall interest in GenAI technologies, enterprises are … Continued

Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells

By API User

ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described genes related to induced Treg anti-inflammatory activities No serious adverse effects or dose limiting toxicities were observed at any dose level, and ATH-063 demonstrated favorable pharmacokinetics (PK) The data provides clinical verification for Athos' Proprietary … Continued